Laura Olbrich,Zoe Franckling-Smith,Leyla Larsson,Issa Sabi,Nyanda Elias Ntinginya,Celso Khosa,Denise Banze,Marriott Nliwasa,Elizabeth Lucy Corbett,Robina Semphere,Valsan Philip Verghese,Joy Sarojini Michael,Marilyn Mary Ninan,Elmar Saathoff,Timothy Daniel McHugh,Alia Razid,Stephen Michael Graham,Rinn Song,Pamela Nabeta,Andre Trollip,Mark Patrick Nicol,Michael Hoelscher,Christof Geldmacher,Norbert Heinrich,Heather Joy Zar,RaPaed-AIDA-TB consortium,Craig Dalgarno,Bariki Mtafya,Harieth Mwambola,Chiristina Manyama,Lwitiho Edwin Sudi,Emanuel Sichone,Daniel Mapamba,Willyhelmina Olomi,Peter Edwin,Anila Chacko,Ramya Kumari,Dhanabhagyam Naveena Krishnan,Nithya Munisamy,Deepa Mani,Cremildo Gomes Maueia,Carla Maria Madeira,Diana Kachere,Tamenji Chinoko,Tionge Daston Sikwese,Alice Mnyanga,Lingstone Chiume,Anna Mantsoki,Cynthia Biddle Baard,Jacinta Diane Munro,Margaretha Prins,Nolufefe Benzi,Linda Claire Bateman,Ashleigh Ryan,Kutala Booi,Nezisa Paulo,Anthenette Heydenrych,Wonita Petersen,Raquel Brookes,Michele Mento,Chad Centner

Abstract:Background: Despite causing high mortality worldwide, paediatric tuberculosis is often undiagnosed. We aimed to investigate optimal testing strategies for microbiological confirmation of tuberculosis in children younger than 15 years, including the yield in high-risk subgroups (eg, children younger than 5 years, with HIV, or with severe acute malnutrition [SAM]). Methods: For this secondary analysis, we used data from RaPaed-TB, a multicentre diagnostic accuracy study evaluating novel diagnostic assays and testing approaches for tuberculosis in children recruited from five health-care centres in Malawi, Mozambique, South Africa, Tanzania, and India conducted between Jan 21, 2019, and June 30, 2021. Children were included if they were younger than 15 years and had signs or symptoms of pulmonary or extrapulmonary tuberculosis; they were excluded if they weighed less than 2 kg, had received three or more doses of anti-tuberculosis medication at time of enrolment, were in a condition deemed critical by the local investigator, or if they did not have at least one valid microbiological result. We collected tuberculosis-reference specimens via spontaneous sputum, induced sputum, gastric aspirate, and nasopharyngeal aspirates. Microbiological tests were Xpert MTB/RIF Ultra (hereafter referred to as Ultra), liquid culture, and Löwenstein-Jensen solid culture, which were followed by confirmatory testing for positive cultures. The main outcome of this secondary analysis was categorising children as having confirmed tuberculosis if culture or Ultra positive on any sample, unconfirmed tuberculosis if clinically diagnosed, and unlikely tuberculosis if neither of these applied. Findings: Of 5313 children screened, 975 were enrolled, of whom 965 (99%) had at least one valid microbiological result. 444 (46%) of 965 had unlikely tuberculosis, 282 (29%) had unconfirmed tuberculosis, and 239 (25%) had confirmed tuberculosis. Median age was 5·0 years (IQR 1·8-9·0); 467 (48%) of 965 children were female and 498 (52%) were male. 155 (16%) of 965 children had HIV and 110 (11%) children had SAM. 196 (82%) of 239 children with microbiological detection tested positive on Ultra. 110 (46%) of 239 were confirmed by both Ultra and culture, 86 (36%) by Ultra alone, and 43 (18%) by culture alone. 'Trace' was the most common semiquantitative result (93 [40%] of 234). 481 (50%) of 965 children had only one specimen type collected, 99 (21%) of whom had M tuberculosis detected. 484 (50%) of 965 children had multiple specimens collected, 141 (29%) of whom were positive on at least one specimen type. Of the 102 children younger than 5 years with M tuberculosis detected, 80 (78%) tested positive on sputum. 64 (80%) of 80 children who tested positive on sputum were positive on sputum alone; 61 (95%) of 64 were positive on induced sputum, two (3%) of 64 were positive on spontaneous sputum, and one (2%) was positive on both. Interpretation: High rates of microbiological confirmation of tuberculosis in children can be achieved via parallel sampling and concurrent testing procedures. Sample types and choice of test to be used sequentially should be considered when applying to groups such as children younger than 5 years, living with HIV, or with SAM. Funding: European and Developing Countries Clinical Trials Partnership programme, supported by the EU, the UK Medical Research Council, Swedish International Development Cooperation Agency, Bundesministerium für Bildung und Forschung, the German Center for Infection Research, and Beckman Coulter.

Limited Utility of Polymerase Chain Reaction in Induced Sputum Specimens for Determining the Causes of Childhood Pneumonia in Resource-Poor Settings: Findings From the Pneumonia Etiology Research for Child Health (PERCH) Study

The Etiology of Pneumonia From Analysis of Lung Aspirate and Pleural Fluid Samples: Findings From the Pneumonia Etiology Research for Child Health (PERCH) Study

Causes of Severe Pneumonia Requiring Hospital Admission in Children Without HIV Infection from Africa and Asia: the PERCH Multi-Country Case-Control Study

The Etiology of Childhood Pneumonia in Mali: Findings From the Pneumonia Etiology Research for Child Health (PERCH) Study

Detection of Mycoplasma pneumoniae in different respiratory specimens

Post-mortem investigation of deaths due to pneumonia in children aged 1-59 months in sub-Saharan Africa and South Asia from 2016 to 2022: an observational study

Is Higher Viral Load in the Upper Respiratory Tract Associated With Severe Pneumonia? Findings From the PERCH Study

Etiology and Clinical Characteristics of Severe Pneumonia Among Young Children in Thailand

Improved Targeting of the 16S Rdna Nanopore Sequencing Method Enables Rapid Pathogen Identification in Bacterial Pneumonia in Children.

Paediatric pulmonary disease—are we diagnosing it right?

Aetiology of pleural effusions in children living in a high TB endemic setting

Assembling a global database of child pneumonia studies to inform WHO pneumonia management algorithm: Methodology and applications

Early Discrimination of Refractory Mycoplasma Pneumoniae Pneumonia in Children: A Multicenter Prospective Study in Zhejiang, China

Colonization Density of the Upper Respiratory Tract As a Predictor of Pneumonia-Haemophilus Influenzae, Moraxella Catarrhalis, Staphylococcus Aureus, and Pneumocystis Jirovecii.

Utility of multiplex real-time polymerase chain reaction for the detection of bacteria from sputum samples of community acquired pneumonia patients: A study from Dhaka, Bangladesh

Sequential and parallel testing for microbiological confirmation of tuberculosis disease in children in five low-income and middle-income countries: a secondary analysis of the RaPaed-TB study

Polymerase Chain Reaction on Respiratory Tract Specimens of Immunocompromised Patients to Diagnose Pneumocystis Pneumonia: A Systematic Review and Meta-analysis

Comparing the yield of oropharyngeal swabs and sputum for detection of 11 common pathogens in hospitalized children with lower respiratory tract infection

Etiology and the challenge of diagnostic testing of community-acquired pneumonia in children and adolescents

The Etiology of Pneumonia in HIV-1-infected South African Children in the Era of Antiretroviral Treatment: Findings From the Pneumonia Etiology Research for Child Health (PERCH) Study

Epidemiology of community-acquired pneumonia among hospitalised children in Indonesia: a multicentre, prospective study